Join an innovative global community focused on improving patient care, shaping effective policy, and ensuring the future of our field.
October 20, 2026
Improve your practice in just three days. CEU 2026 begins on October 22 and delivers guidance on diabetes, obesity, thyroid disease, pituitary disorders, and more. Earn CME, stay current on the latest treatments, and leave with strategies you can apply immediately to your work. There is still time to join, but don't wait. Register now.
October 13, 2026
Your collaboration opportunities have been extended to Tuesday, October 20 for Reimagining Diabetes: From Molecular Mechanisms to Transformative Therapies, a joint meeting with Keystone Symposia, February 1-4 in Keystone, CO. Delve into groundbreaking discoveries in diabetes biology, innovative therapeutic approaches, and emerging research technologies. Apply now for a scholarship or submit your short talk abstract.
October 20, 2026
The Fee Artificial Intelligence Summit begins tomorrow, October 21, and is reshaping endocrine care, from thyroid disease management to clinical decision-making. Included with your CEU registration, the AI Summit explores how these advances may affect your practice and your patients. Join CEU 2026 and stay ahead of what's next in endocrinology.
October 06, 2026
Your membership is set to expire Thursday, December 31. Renew your membership to invest in a global community that advances research, strengthens clinical care, develops future leaders, and accelerates progress in endocrine health.
October 02, 2026
Read our latest Advocacy in Action for information on the Society's campaign to block the OMB Proposed Rule; our response to NIH RFI on the Development of Clinical Trial Investigators and our opposition to changes to K Awards; our move to join the national effort on Capitol Hill to advance women’s health.
Need more info?
Learn more about the advantages of membership
October 19, 2026
The Endocrine Society applauds the White House’s executive order led by First Lady Melania Trump to advance research and improve care for women and girls throughout every stage of life.
October 13, 2026
Alzheimer’s disease and dementia may be more common in women with polyendocrine metabolic ovarian syndrome (PMOS), formerly known as polycystic ovary syndrome (PCOS), according to a review of existing evidence published in the Journal of the Endocrine Society.
October 08, 2026
People with type 2 diabetes who sleep longer may have an increased risk of developing or worsening existing diabetic kidney disease, according to a study published in the Journal of the Endocrine Society.
January 20, 2026
The authors present a 34-year-old woman with acromegaly who underwent transsphenoidal surgery for an invasive pituitary macroadenoma, which was followed by the development of panhypopituitarism.
January 20, 2026
This work aims to determine the role of γ-aminobutyric acid B (GABAB) receptors in Kiss1 cells, studying the effect on central and peripheral systems that regulate reproduction and metabolic homeostasis in Kiss1-GABAB1KO female mice during development and adulthood.
January 20, 2026
We test the hypothesis that the ketogenic diet would decrease de novo lipogenesis and liver fat, which would be associated with restored beta-cell function.
